INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 445m ago
HOUSE PTR45m ago
SEC 13F44m ago
ROBINHOOD CHAIN44m ago
TD
Corporate insider

Torres Denice

DirectorCIK 0001820278

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score15
Connections with evidence2

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TD
Torres DeniceDirector
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
26.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Celldex Therapeutics, Inc.Director · Jun 29, 2026
  • Insider ofevidence
    GLAUKOS CorpDirector · Jan 7, 2026
13
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A
—
1,878 sh
May 28, 2026
Jun 1, 2026
traded May 28, 2026
+4d
SEC FORM 4

Evidence

9
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A—
2,987 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

15
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A—
623 sh
Jan 2, 2026Jan 7, 2026
traded Jan 2, 2026
+5dSEC FORM 4

Evidence